NCT02643420 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 196
- group Id
- BG001
- value
- 210
- group Id
- BG002
- value
- 406
- units
- Participants
- groups
- description
- Participants received SPI-2012 13.2 mg/0.6mL (3.6 mg G-CSF) fixed-dose SC injection once per cycle on Day 2 of each cycle up to Cycle 4 (each cycle was 21 days), approximately 24-26 hours after TC chemotherapy administration. TC chemotherapy was administered on Day 1 of each cycle and included Docetaxel 75 mg/m\^2 IV infusion and Cyclophosphamide 600 mg/m\^2 IV infusion per institute's standard of care.
- id
- BG000
- title
- Arm 1: SPI-2012 and TC
- description
- Participants received pegfilgrastim 6 mg SC injection once per cycle on Day 2 of each cycle up to Cycle 4 (each cycle was 21 days), approximately 24-26 hours after TC chemotherapy administration. TC chemotherapy on Day 1 of each cycle included Docetaxel 75 mg/m\^2 IV infusion and Cyclophosphamide 600 mg/m\^2 IV infusion per institute's standard of care.
- id
- BG001
- title
- Arm 2: Pegfilgrastim and TC
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.12
- value
- 59.9
- group Id
- BG001
- spread
- 11.79
- value
- 59.0
- group Id
- BG002
- spread
- 11.47
- value
- 59.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 209
- group Id
- BG002
- value
- 404
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 34
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 74
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 162
- group Id
- BG001
- value
- 170
- group Id
- BG002
- value
- 332
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 156
- group Id
- BG001
- value
- 159
- group Id
- BG002
- value
- 315
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 58
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 18
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 12
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The Intent to Treat (ITT) population included all participants who were randomized.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 196
- group Id
- BG001
- value
- 210
- group Id
- BG002
- value
- 406
- units
- Participants
- groups
- description
- Participants received SPI-2012 13.2 mg/0.6mL (3.6 mg G-CSF) fixed-dose SC injection once per cycle on Day 2 of each cycle up to Cycle 4 (each cycle was 21 days), approximately 24-26 hours after TC chemotherapy administration. TC chemotherapy was administered on Day 1 of each cycle and included Docetaxel 75 mg/m\^2 IV infusion and Cyclophosphamide 600 mg/m\^2 IV infusion per institute's standard of care.
- id
- BG000
- title
- Arm 1: SPI-2012 and TC
- description
- Participants received pegfilgrastim 6 mg SC injection once per cycle on Day 2 of each cycle up to Cycle 4 (each cycle was 21 days), approximately 24-26 hours after TC chemotherapy administration. TC chemotherapy on Day 1 of each cycle included Docetaxel 75 mg/m\^2 IV infusion and Cyclophosphamide 600 mg/m\^2 IV infusion per institute's standard of care.
- id
- BG001
- title
- Arm 2: Pegfilgrastim and TC
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.12
- value
- 59.9
- group Id
- BG001
- spread
- 11.79
- value
- 59.0
- group Id
- BG002
- spread
- 11.47
- value
- 59.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 209
- group Id
- BG002
- value
- 404
- title
- Female
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 34
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 74
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 162
- group Id
- BG001
- value
- 170
- group Id
- BG002
- value
- 332
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 156
- group Id
- BG001
- value
- 159
- group Id
- BG002
- value
- 315
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 58
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 18
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 12
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The Intent to Treat (ITT) population included all participants who were randomized.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle